Compare ANIP & JAMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | JAMF |
|---|---|---|
| Founded | 2001 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | N/A | 2020 |
| Metric | ANIP | JAMF |
|---|---|---|
| Price | $81.59 | $12.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 12 |
| Target Price | ★ $102.14 | $16.01 |
| AVG Volume (30 Days) | 438.9K | ★ 2.4M |
| Earning Date | 11-07-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | ★ $826,880,000.00 | $690,590,000.00 |
| Revenue This Year | $43.41 | $15.46 |
| Revenue Next Year | $9.66 | $9.19 |
| P/E Ratio | $49.04 | ★ N/A |
| Revenue Growth | ★ 48.87 | 12.28 |
| 52 Week Low | $52.50 | $7.09 |
| 52 Week High | $99.50 | $16.12 |
| Indicator | ANIP | JAMF |
|---|---|---|
| Relative Strength Index (RSI) | 35.76 | 76.67 |
| Support Level | $80.57 | $12.91 |
| Resistance Level | $83.60 | $13.00 |
| Average True Range (ATR) | 2.45 | 0.03 |
| MACD | 0.15 | -0.07 |
| Stochastic Oscillator | 36.70 | 85.71 |
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.